Drug Shortage Report for TARO-ZOLEDRONIC ACID CONCENTRATE
Report ID | 175655 |
Drug Identification Number | 02415186 |
Brand name | TARO-ZOLEDRONIC ACID CONCENTRATE |
Common or Proper name | ZOLEDRONIC |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | ZOLEDRONIC ACID |
Strength(s) | 4MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 5ML |
ATC code | M05BA |
ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-11-19 |
Estimated end date | 2023-11-24 |
Actual end date | 2023-11-28 |
Shortage status | Resolved |
Updated date | 2024-01-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.